1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Amyotrophic Lateral Sclerosis ALS: new trials by email Literature Review of Amyotrophic Lateral Sclerosis ALS trials Research Report on Amyotrophic Lateral Sclerosis ALS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments Astaxanthin, Protandim, Melatonin - Amyotrophic Lateral Sclerosis ALS | Phase 2 | Completed | Duke University | 50 | 2024-06-12 | 2026-10-27 |
Amyotrophic Lateral Sclerosis (1)
Central Nervous System Diseases (1) · Metabolic Diseases (1) · Motor Neuron Disease (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Nutritional and Metabolic Diseases (1) · Proteostasis Deficiencies (1) · Spinal Cord Diseases (1) · TDP-43 Proteinopathies (1)
Melatonin (1) · Protandim (1) · astaxanthine (1) · mitoquinone (1)
Duke University (1)
United States (1)